DashboardPortfoliosWatchlistCommunityDiscoverScreener
NOT FOR DISTRIBUTION

Bio-Rad Laboratories, Inc.

NYSE:BIO Stock Report

Market Cap: US$9.9b

  • Company Overview
    • Valuation
    • Future Growth
    • Past Performance
    • Financial Health
    • Dividend
  • Management
  • Ownership
  • Other Information
  • Stock Community

Bio-Rad Laboratories Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NYSE:BIO Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
11 May 26SellUS$135,597Eva EngelhardtIndividual550US$246.54
06 Nov 25SellUS$214,289James BarryIndividual699.87US$306.18

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of BIO?
Owner TypeNumber of SharesOwnership Percentage
State or Government12,5080.0468%
Individual Insiders1,278,6404.78%
General Public1,737,1966.5%
Private Companies4,094,39415.3%
Institutions19,615,43773.4%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 72.18% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
15.2%
Blue Raven Partners, L.P.
4,060,054US$1.5b0%no data
9.75%
First Eagle Investment Management, LLC
2,606,219US$960.4m0.13%0.84%
6.35%
BlackRock, Inc.
1,698,929US$626.1m1.12%0.01%
4.58%
Norman Schwartz
1,225,375US$451.6m-28%no data
3.53%
Dimensional Fund Advisors LP
944,548US$348.1m-13.3%0.04%
3.52%
Vanguard Capital Management, LLC
941,375US$346.9m-0.36%0.01%
3.39%
Capital Research and Management Company
905,940US$333.9m8.42%0.01%
3.05%
Ariel Investments, LLC
816,751US$301.0m3.92%2.87%
3.05%
Vanguard Portfolio Management, LLC
816,198US$300.8m-1.57%0.01%
2.72%
UBS Asset Management AG
727,222US$268.0m-6.82%0.02%
2.17%
EARNEST Partners, LLC
580,752US$214.0m-1.36%0.77%
2.14%
State Street Investment Management
571,762US$210.7m1.87%0.01%
1.5%
First Pacific Advisors, LP
401,861US$148.1m-1.35%1.26%
1.43%
Managed Account Advisors LLC
382,498US$141.0m-1.32%0.02%
1.3%
Geode Capital Management, LLC
347,575US$128.1m-4.69%0.01%
1.23%
Nomura Holdings, Inc.
328,897US$121.2m51.3%0.25%
1.02%
SEI Investments Company
273,377US$100.7m-5.05%0.07%
1%
Barclays PLC
266,387US$98.2m-2.59%0.05%
0.87%
Assenagon Asset Management S.A.
233,227US$85.9m57.8%0.09%
0.85%
Deerfield Management Company, L.P.
226,070US$83.3m0%1.49%
0.82%
Northern Trust Global Investments
218,285US$80.4m-0.1%0.01%
0.73%
Charles Schwab Investment Management, Inc.
195,538US$72.1m-0.52%0.01%
0.72%
AQR Capital Management, LLC
192,638US$71.0m104%0.02%
0.64%
SG Americas Securities, LLC
170,802US$62.9m155%0.04%
0.62%
GW&K Investment Management, LLC
166,905US$61.5m-4.47%0.5%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/09/14 21:42
End of Day Share Price 2026/09/14 00:00
Earnings2026/06/30
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
  • SEC Form 10-K
  • SEC Form 10-Q
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
  • Analyst Research Reports
  • Blue Matrix
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
  • ICE Market Data
  • SEC Form S-1
Ownership10 years
  • Top shareholders
  • Insider trading
  • SEC Form 4
  • SEC Form 13D
Management10 years
  • Leadership team
  • Board of directors
  • SEC Form 10-K
  • SEC Form DEF 14A
Key Developments10 years
  • Company announcements
  • SEC Form 8-K

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Bio-Rad Laboratories, Inc. is covered by 20 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jon WoodBofA Global Research
Yuan ZhiB. Riley Securities, Inc.
Patrick DonnellyCitigroup Inc

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide